BOARD MEMBER

Markus Einzelberger, PhD

Partner, Versant Ventures

Markus Enzelberger is a partner located in Basel where he plays a central role in the launch of future newcos from Versant’s Ridgeline Discovery Engine.
He is a seasoned executive with deep domain knowledge of drug discovery and development, especially in the protein field. Markus most recently was CSO and a member of the management board of MorphoSys. He joined the company in 2002 and is recognized as an authority in the field of protein engineering.
Markus holds a Ph.D. from the Technical University of Stuttgart, Germany.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close